Meet Alastair Watson
Alastair Watson is the Vice President of Marketing at Radiation Detection Company, where he leads the company’s marketing strategy and demand generation efforts to drive growth and brand awareness. With a strong background in B2B marketing, digital strategy, and revenue-focused campaign execution, Alastair ensures RDC reaches and engages its target audiences effectively.
Professional Experience
Alastair oversees all aspects of marketing at RDC, including go-to-market planning, content development, digital channels, and analytics. His leadership is focused on aligning marketing with sales and product to accelerate pipeline, strengthen customer relationships, and support RDC’s continued expansion in radiation safety solutions across healthcare, veterinary, dental, nuclear, and industrial markets.
Prior to joining RDC, Alastair held senior marketing roles at both private and PE-backed companies, including Momentive Software, Community Brands, First Advantage, and Foundation AI. In each of these roles, he was instrumental in repositioning brands, scaling marketing operations, and accelerating pipeline impact. He’s known for bringing clarity, structure, and an innovation-driven mindset to marketing strategy – and for building strong partnerships across sales, product, and executive teams.
Alastair holds a degree in English from the University of Florida and resides in St. Petersburg, Florida.
Alastair’s Impact at RDC
At RDC, Alastair is focused on driving marketing innovation that fuels growth and positions the company as a leader in radiation safety solutions. His efforts are helping RDC extend its reach among hospitals, imaging centers, and other healthcare providers, as well as veterinary, dental, and specialty industrial segments.
Through high-impact campaigns, optimized marketing operations, and a digitally enabled approach, Alastair is committed to elevating RDC’s visibility, accelerating customer-centric growth, and delivering measurable value that reflects our commitment to providing industry-leading dosimetry service.
